nivolumab,ipilimumab
bms
['yervoy', 'lung', 'opdivo', 'o/y', 'bristol']
bristol myers' opdivo/yervoy combo shows durable results in lung cancer patients at 4-year follow-up. bmy shares up 0.18% in premarket. #bmy #asco #positive 
Real-time news analysis & sentiment scoring for the stocks in the S&P500
Powered by @streetbeat_com of @gptnewstracker
Disclosure: https://t.co/sjkSk4W05p